Summary of Product Characteristics
last updated on the eMC:
24/09/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 24/09/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
| Date of revision of text on the SPC: 28-Jan-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Changed the date of revision of the text (previous error)
|
|
Updated on 02/07/2009 and displayed until 24/09/2009
|
Reasons for adding or updating:
|
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 28-Jan-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| MA Renewal
|
|
Updated on 06/09/2007 and displayed until 02/07/2009
|
Reasons for adding or updating:
|
-
Change to section 6. 5 - Nature and Contents of Container
|
| Date of revision of text on the SPC: 10/2006 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 6.5 Nature and Contents of Container now reads:
REMEDEINE tablets are available in polyethylene containers with polypropylene lids containing 56 or 112 tablets.
REMEDEINE FORTE tablets are available in ployehtylene containers with polypropylene lids containing 56 tablets.
|
|
Updated on 02/03/2007 and displayed until 06/09/2007
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 10/2006 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 4.4 Risk benefit statement added
Section 4.8 Regular prolonged use of DHC leading to tolerance and addiction statement added. painkiller and headaches statement added.
|
|
Updated on 23/03/2006 and displayed until 02/03/2007
|
Reasons for adding or updating:
|
-
Change to section 10 (date of (partial) revision of the text
-
Change to section 4.9 - Overdose
|
|
Updated on 20/03/2006 and displayed until 23/03/2006
|
Reasons for adding or updating:
|
-
Change to section 4.9 - Overdose
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 14/09/2004 and displayed until 20/03/2006
|
Reasons for adding or updating:
|
-
Change to section 6. 5 - Nature and Contents of Container
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 28/08/2001 and displayed until 14/09/2004
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 20/10/2000 and displayed until 28/08/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 20/10/2000
|
Reasons for adding or updating:
|
|
|
|